MESOMARK™: A Potential Test for Malignant Pleural Mesothelioma
Author(s) -
Heather L Beyer,
Ryan Geschwindt,
Curtis L. Glover,
Lý Thị Trần,
Ingegerd Hellström,
Karl-Erik Hellstrom,
Michael Craig Miller,
Thorsten Verch,
W. Jeffrey Allard,
Harvey I. Pass,
Niranjan Y. Sardesai
Publication year - 2007
Publication title -
clinical chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.705
H-Index - 218
eISSN - 1530-8561
pISSN - 0009-9147
DOI - 10.1373/clinchem.2006.079327
Subject(s) - mesothelioma , medicine , confidence interval , bilirubin , analyte , gastroenterology , chemistry , pathology , nuclear medicine , chromatography
Soluble mesothelin-related peptides (SMRP)have been reported to be potential biomarkers for malignant pleural mesothelioma (MPM). We report analytical and preliminary clinical studies of MESOMARK, a quantitative assay for SMRP.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom